RxDoctor Payments Data

Tak Kwan, MD

Interventional Cardiology · New York, NYNPI 1639130925

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $49,222 of the $71,835 with a category attached, or 68.5%. It is spread thinly across 36 manufacturers, the largest accounting for just 21.7%. 2025 is the largest year on record at $25,058, 3.8 times the $6,539 reported in 2019.

$71,835in general payments, 2019–2025

Across 632 payments — averaging $113.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spectrawave, Inc$16K
  • Shockwave Medical, Inc$12K
  • Endologix LLC$10K
  • Boston Scientific$8K
  • Abbott$6K
  • Cardiovascular Systems Inc.$6K
  • plus $15K from 30 others
$501,068in ownership & investment interests, 2019–2025

Across 2 payments — averaging $250,534 each. An ownership or investment interest held by the physician or an immediate family member.

  • Spectrawave, Inc$501K

What the payments were for

  • Consulting fees$11,50016%
  • Speaking & faculty fees$6,6009%
  • Travel & lodging$4,3086%
  • Food & beverage$49,22269%
  • Education$2050%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$71,835 in reported general payments places this provider in the 85th percentile of 382 interventional cardiology providers in New York.

See all interventional cardiology providers in New York

Medicare billing

Part B allowed, 2024
$57,739
Medicare patients
25
Services billed
126

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →